TOP-1288

DB14839InvestigationalSmall molecule

TOP-1288 is under investigation in clinical trial NCT02888379 (Phase 2a Study to Evaluate the Safety/Tolerability and Efficacy of TOP1288 200 mg Rectal Solution Once Daily for 4 Weeks in Ulcerative...

Formula / weight: C₄₃H₄₉N₇O₉S · 839.97 g/mol (avg)
Code names: TOP1288

Resolves to

Compound

UNII19ZTZ9YC4OCAS1630202-02-6ChEMBLCHEMBL3681949

Structure

InChIKeyFWXVGKSWZJEPQI-UHFFFAOYSA-NSMILESCOCCOCCOCCNC(=O)C1=CC(=CC(NC2=NC=CC(OC3=C4C=CC=CC4=C(NC(=O)NC4=CC(=CC(NS(C)(=O)=O)=C4OC)C(C)(C)C)C=C3)=N2)=C1)C#C

What you can answer from here — as of June 12, 2020

2Clinical trialsPhase, status and sponsor resolved per trial

Which companies are running trials of TOP-1288, in which indications and phases, and which of those programs are still active?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account